Table 2.

Associations between each inflammatory marker and clinical characteristics

	hsCRP			hsIL-6
	rho		p value	rho		p value
Age (years)	0.26		0.0009	0.32		<0.0001
Ejection fraction (%)	−0.174		0.89	−0.21		0.098
BMI (kg/m2)	0.44		<0.0001	0.28		0.0003
	hsCRP (mg/dL)		p value	hsIL-6 (pg/ml)		p value
Race
White	3.1 (1.2–6.9)			2.3 (1.2–4.6)
Black	5.5 (2.7–10.8)			5.0 (3.3–8.9)
Asian	2.1 (0.9–3.4)			1.6 (0.8–3.0)
Latino	2.9 (1.1–4.6)		0.23	2.2 (1.2–3.3)		0.30
	With covariate	Without covariate	p value	With covariate	Without covariate	p value
Male	3.0 (1.2–7.1)	2.7 (1.1–6.4)	0.72	2.3 (1.1–4.8)	2.1 (0.9–3.6)	0.43
Hypertension	5.7 (2.3–8.4)	2.3 (0.9–5.1)	0.0004	2.6 (1.7–6.5)	2.0 (0.8–4.3)	0.0064
Type II diabetes	3.3 (2.2–8.4)	2.7 (1.1–6.4)	0.29	3.3 (1.8–8.9)	2.2 (1.0–4.3)	0.062
Coronary artery disease	2.3 (1.6–8.8)	2.9 (1.1–6.4)	0.83	3.9 (2.1–9.7)	2.1 (0.9–4.2)	0.0066
Congestive heart failure	8.4 (4.1–10.0)	2.7 (1.1–6.3)	0.016	5.0 (2.3–16.2)	2.2 (1.0–4.3)	0.028
Creatinine>1.5 mg/dL	7.6 (6.4–8.9)	2.7 (1.1–6.4)	0.15	24.6 (1.7–47.5)	2.3 (1.1–4.5)	0.36
Statin	3.5 (2.1–8.4)	2.6 (0.9–5.9)	0.065	2.8 (1.7–5.5)	2.0 (0.9–3.8)	0.013
ACE inhibitor or ARB	4.8 (1.5–10.0)	2.7 (1.1–6.4)	0.29	5.4 (2.7–10.1)	2.05 (0.9–3.6)	0.001
Aspirin	3.4 (1.6–6.4)	2.5 (1.1–6.4)	0.38	2.3 (1.7–3.7)	2.2 (0.9–4.6)	0.44

Interquartile ranges are given in parentheses

ARB denotes angiotensin receptor blocker